• On 05 May 2021, the Food and Drug Administration (FDA) issued authorization (as amended on 2 September 2021) granting Zuellig Pharma Corporation the emergency use approval of COVID-19 mRNA Vaccine (nucleoside modified) [COVID-19 Vaccine Moderna].

Fact Sheet for Healthcare Providers Administering the Vaccine
English    Tagalog
Fact Sheet for Recipients and Caregivers
English    Tagalog

• The COVID-19 Vaccine Moderna is authorized on the basis of regulatory reliance to the European Medicines Agency  and United States Food and Drug Administration.
• Information regarding COVID-19 Vaccine Moderna is being updated regularly and is available here.
• Information on the safety of COVID-19 Vaccine Moderna is discussed in their comprehensive Risk Management Plan.
• For more information on reporting side effects, click here.